Copy to clipboard 
Olympus has acquired FH ORTHO, supporting Olympus’ focus on expanding in the field of orthopedic minimally invasive surgery (MIS) organically and through M&A. FH’s spine products, the LP-ESP® lumbar disc replacement and the CP-ESP® cervical disc replacement, are not included in the transaction; the line was spun out to Spine Innovations as announced in October.
FH ORTHO allows Olympus to build on its portfolio used in MIS procedures in ligament repair, foot & ankle, and trauma surgery.
Olympus is presently active in orthopedics in Japan, where its joint venture Olympus Terumo Biomaterials distributes bone substitutes and high tibial osteotomy (HTO) plates and screws. Olympus has also developed the first ultrasound device indicated for arthroscopic surgery.
The acquisition of FH ORTHO will expand the distribution of Olympus’ orthopedic products via FH ORTHO’s existing distribution channels, and will introduce certain FH ORTHO products in Japan.
Based in France, FH is represented in over 37 countries with products for joint reconstruction (shoulder, knee and ankle), ligament repair, biologics, foot/ankle and other trauma applications.
“We are pleased to integrate FH ORTHO’s product portfolio, market reach and talented people to our orthopedics business,” says Toshihiko Okubo, Senior Vice President, New Business Development, Global at Olympus. “By combining FH ORTHO’s expertise and its excellent business presence with our products and solutions for the minimally invasive orthopedics surgery, the benefit of our offer to the patients and healthcare professionals will be further enhanced across the world.”
Olympus has acquired FH ORTHO, supporting Olympus' focus on expanding in the field of orthopedic minimally invasive surgery (MIS) organically and through M&A. FH's spine products, the LP-ESP® lumbar disc replacement and the CP-ESP® cervical disc replacement, are not included in the transaction; the line was spun out to Spine Innovations as...
Olympus has acquired FH ORTHO, supporting Olympus’ focus on expanding in the field of orthopedic minimally invasive surgery (MIS) organically and through M&A. FH’s spine products, the LP-ESP® lumbar disc replacement and the CP-ESP® cervical disc replacement, are not included in the transaction; the line was spun out to Spine Innovations as announced in October.
FH ORTHO allows Olympus to build on its portfolio used in MIS procedures in ligament repair, foot & ankle, and trauma surgery.
Olympus is presently active in orthopedics in Japan, where its joint venture Olympus Terumo Biomaterials distributes bone substitutes and high tibial osteotomy (HTO) plates and screws. Olympus has also developed the first ultrasound device indicated for arthroscopic surgery.
The acquisition of FH ORTHO will expand the distribution of Olympus’ orthopedic products via FH ORTHO’s existing distribution channels, and will introduce certain FH ORTHO products in Japan.
Based in France, FH is represented in over 37 countries with products for joint reconstruction (shoulder, knee and ankle), ligament repair, biologics, foot/ankle and other trauma applications.
“We are pleased to integrate FH ORTHO’s product portfolio, market reach and talented people to our orthopedics business,” says Toshihiko Okubo, Senior Vice President, New Business Development, Global at Olympus. “By combining FH ORTHO’s expertise and its excellent business presence with our products and solutions for the minimally invasive orthopedics surgery, the benefit of our offer to the patients and healthcare professionals will be further enhanced across the world.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
